The Cooper Companies, Inc.

NASDAQ:COO

Medical - Instruments & Supplies

Healthcare
$60.75 -3.42%

-$2.30 today

Market cap
$11.55B
Beta
0.87
P/E (TTM)
53.8
EPS (TTM)
$1.21
52W Low $58.89High $89.83

Volume 2.20M

Average 2.55M

COO Sales of Investments

Cash received from selling or redeeming investments.

The Cooper Companies, Inc.NASDAQ: COO

Sales of Investments · Q3 FY2026 · quarter ended Jul 2026

Sales of investments outflow grows to $0

Q3 FY2026 sales of investments was $0, compared with $0 a year earlier. Trailing-twelve-month sales of investments was $0.

Context

  • Sales of investments amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Sales of investments increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly sales of investments holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJul 2026
$0— QoQ
Last fiscal yearOct 2025
$0— YoY
LTMJul 2026
$0— YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
0 USD
Year-over-year change
—

Sales of Investments vs competitors

How COO compares with its peers on the latest reported figures

  • COO's LTM Jul 2026 sales of investments of $0 is the smallest of the 6 companies compared; the peer median is $13.75M.
  • Sales of investments amounts to 0.0% of revenue for COO, versus a peer median of 23.8%.
COO Competitors Peer median
Sales of Investments for COO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GKOSGlaukos CorporationLTM Jun 2026$185.16M -22.8%+13.4%30.2%
STAASTAAR Surgical CompanyLTM Apr 2026$83.12M +11.5%+93.8%28.6%
LNSRLENSAR, Inc.LTM Mar 2026$13.75M +28.0%—23.8%
BLCOBausch + Lomb CorporationLTM Jun 2026$7.92M -32.6%-28.6%0.1%
ALCAlcon Inc.LTM Sep 2026$7M -95.3%+24.9%0.1%
COOThe Cooper Companies, Inc.LTM Jul 2026$0 ——0.0%
Peer median (excluding COO) $13.75M-22.8%+19.2%23.8%

Competitors are the stored peer set for COO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Net Income2.94B385.8M294.2M392.3M374.9M
Depreciation & Amortization309.3M346.1M367.7M375.1M423M
Deferred Income Tax(2.5B)53.9M44.7M118.9M135.2M
Stock-Based Compensation00000
Change in Working Capital(149.9M)(174M)(218.8M)(333.7M)(284.8M)
Accounts Receivables(75.5M)(33.8M)(60.2M)(117.1M)(120.3M)
Inventory(9.2M)(40.4M)(105.4M)(59.3M)(46M)
Accounts Payables(16M)49.9M5.5M9.3M8M
Other Working Capital(49.2M)(149.7M)(58.7M)(166.6M)(126.5M)
Other Non-Cash Items136.7M80.6M119.7M156.7M147.8M
Operating Cash Flow738.6M692.4M607.5M709.3M796.1M
Capital Expenditures(214.4M)(242M)(392.5M)(421.2M)(362.4M)
Acquisitions (Net)0(1.59B)(56.5M)(343.4M)(10.5M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(235.9M)0000
Investing Cash Flow(450.3M)(1.83B)(449M)(764.6M)(372.9M)
Debt Repayment(309.9M)1.28B(180.8M)5.6M(79.9M)
Common Stock Issued26.3M16.1M23M63.9M16M
Common Stock Repurchased(24.8M)(78.5M)00(290.1M)
Dividends Paid(3M)(3M)(3M)00
Other Financing Activities0(19.7M)(13.1M)(30.3M)(71.9M)
Financing Cash Flow(311.4M)1.19B(173.9M)39.2M(425.9M)
Effect of Forex Changes2.6M(12.6M)(2.3M)2.9M5.6M
Net Change in Cash(20.5M)42.3M(17.7M)(13.2M)2.9M
Free Cash Flow524.2M450.4M215M288.1M433.7M

The Cooper Companies, Inc.

NASDAQ:COO

Intrinsic Alpha fair value

Locked

Current Price

$60.75

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.